Schurink CA, et al.

About this article: "In this prospective study a Bayesian decision tree for the diagnosis of VAP is proposed. The AUC of this model was 0.857. This model has to be validated prospectively."

Ramírez P. at al.

About this article: "In this review article authors provide current and past information about the utility and indications of bronchoalveolar lavage (including VAP). The article reviews the different diagnostic tests that can be performed in BAL samples."

Rios FG. et al.

About this article: "This study describes the risk factors for Gram negative microorganisms causing VAP only sensitive to colistin. These cases of VAP can be treated effectively with IV colistin in monotherapy."

Weber DJ. et al. 

About this article: "The microbiology of HAP (no VAP) it is not well known. In this retrospective study of 588 episodes of pneumonia, 247 of them were HAP. These patients had similar incidence of MRSA but lower of P.aeruginosa. However, the final conclusion was that HAP has to be treated with similar empiric antibiotics than VAP patients."

Neofytos D. et al.

About this article: "Staphylococcal cassette chromosome mec type IV methicillin may be one of the causative strains of MSA VAP pneumonia. Mortality was not different between strains."

Veelo DP. et al.

About this article: "This is a retrospective study showing that in a setting of selective digestive decontamination, tracheotomized patients have a very low incidence of VAP and it is mainly caused by Staphilococcus aureus meticillin sensitive."

Labeau S. et al. 

About this article: "Developing questionnaires to check measures of VAP prevention is a useful way to detect pitfalls and errors in VAP prevention. These questionnaires have to be reliable and with demonstrated internal and external validity."

Blot SI. et al. 

About this article: "This is another study about the Flemish questionnaire on VAP prevention measures. Obviously the level of knowledge was higher among more experienced nurses (>1 year of experience)."

Omrane R, et al.

About this article: "This is one of the few studies that not demonstrate reduction in VAP incidence after the implementation of prevention measures. This is probably due to the low number of episodes of VAP before implementation."

Hunter J. et al.

Cassandra D. Salgado et al. 

Objective: To review the literature summarizing important aspects of infection control in the critical care setting and to provide recommendations to reduce infections with resistant bacteria in the intensive care unit.

Rosenthal V et al.

Objective: To ascertain the incidence of device-associated infections in the ICUs of developing countries.

Marin H. Kollef, MD et al. 

Objective: To synthesize the available clinical data for the prevention of hospital-associated pneumonia (HAP) and ventilator-associated pneumonia (VAP) into a practical guideline for clinicians.

Peter Dodek, MD, MHSc et al.

Background: Ventilator-associated pneumonia (VAP) is an important patient safety issue in critically ill patients.

A Survey Based on the Opinions of an International panel of Intensivists 

Objective: Adherence to clinical practice guidelines is highly variable. Our objective was to review barriers to physicians’ adherence to evidence-based guidelines (EBGs) for preventing ventilator-associated pneumonia (VAP).

Deborah Cook, MD et al. 

Objective: Ventilator-associated pneumonia (VAP) is a serious complication of critical illness, conferring increased morbidity and mortality. Many interventions have been studied to reduce the risk of VAP. We systematically reviewed the influence of airway management on VAP in critically ill patients.